Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Editorial comment on "Outcomes and management of Peyronie's disease with combined treatment of collagenase clostridium histolyticum, vacuum erection device, and tadalafil".
Journal: Asian journal of andrology
Published: March 05, 2025
Clinical Significance of Shortened Penile Length and Alterations in Penile Length Following Treatment for Peyronie's Disease.
Journal: Sexual medicine reviews
Published: April 10, 2021
Human Pharmacokinetics and Safety of Subcutaneous Collagenase Clostridium Histolyticum in Women.
Journal: Journal of drugs in dermatology : JDD
Published: October 07, 2020
Fibroproliferative disorders and diabetes: Understanding the pathophysiologic relationship between Peyronie's disease, Dupuytren disease and diabetes.
Journal: Endocrinology, diabetes & metabolism
Published: June 29, 2020
Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute Phase Peyronie's Disease: A Multi-institutional Analysis.
Journal: Urology
Published: April 06, 2020
Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase clostridium Histolyticum for Peyronie's Disease.
Journal: The Journal of urology
Published: January 11, 2020
Sixty years in the making: collagenase Clostridium histolyticum, from benchtop to FDA approval and beyond.
Journal: World journal of urology
Published: March 02, 2019
Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis.
Journal: The Journal of urology
Published: January 24, 2019
Collagenase Clostridium histolyticum for the Treatment of Peyronie's Disease: The Development of This Novel Pharmacologic Approach.
Journal: The journal of sexual medicine
Published: May 06, 2015
Last Updated: 09/26/2026